ROCKAWAY, N.J. , Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s CEO, Dan Goldberger, is scheduled to participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1
Seventh consecutive record quarterly net sales of $6.1 million , an increase of 73% over second quarter 2023 Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ROCKAWAY, N.J. , Aug. 07, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc.
ROCKAWAY, N.J. , Aug. 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on August 1, 2024 , Stephen Smith joined electroCore as the Company’s VP, Quality, Regulatory, and Compliance,